Seems to be the same wording as the quarterly so basically no progress. No cash and basically no progress even though the quarterly said ‘within the month’. Same ol’ same ol’.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%